Skip to content

Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe

https://pubmed.ncbi.nlm.nih.gov/10928154/

This randomized study compared the outcomes for patients receiving Mistletoe Therapy and Chemoradiation versus those just receiving Chemoradiation found that those receiving the Mistletoe Therapy experienced more time without disease progression and lived longer.

Share on facebook
Share on email
Share on twitter
Share on linkedin

More on Mistletoe Therapy

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments